Song Da - Thanh Hoa JSC (HNX:THS)

Verve Therapeutics Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2019	FY 2018	FY 2015
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018	Dec 31, 2015
Market Capitalization	41,580	23,220	27,000	24,300	30,510	18,630
Market Cap Growth	14.58%	-14.00%	11.11%	-20.35%	63.77%	9.52%
Enterprise Value	123,571	58,810	38,524	33,931	40,141	13,827
Last Close Price	15400.00	8094.12	8773.68	5476.61	5700.77	2387.16
PE Ratio	47.84	21.33	11.44	7.77	4.35	5.87
PS Ratio	0.13	0.09	0.12	0.09	0.11	0.10
PB Ratio	1.11	0.59	0.67	0.64	0.75	0.53
P/TBV Ratio	1.11	0.59	0.67	0.64	0.75	0.53
P/FCF Ratio	-	-	-	1.90	-	-
P/OCF Ratio	-	-	-	1.50	-	-
EV/Sales Ratio	0.40	0.22	0.17	0.12	0.14	0.07
EV/EBITDA Ratio	20.85	10.48	5.23	9.06	4.32	7.60
EV/EBIT Ratio	44.11	22.75	8.97	20.12	5.55	166.99
EV/FCF Ratio	-5.17	-	-	2.66	-	-
Debt / Equity Ratio	2.73	1.77	0.67	0.14	0.39	0.39
Debt / EBITDA Ratio	17.29	12.41	3.66	1.48	1.73	7.64
Debt / FCF Ratio	-	-	-	0.43	-	-
Asset Turnover	2.19	2.75	-	3.74	-	2.90
Inventory Turnover	5.03	6.65	-	8.52	-	10.88
Quick Ratio	0.30	0.50	0.53	0.48	0.41	0.51
Current Ratio	0.78	1.15	1.46	1.40	1.35	1.31
Return on Equity (ROE)	2.27%	2.73%	-	7.90%	-	9.12%
Return on Assets (ROA)	1.23%	1.66%	-	1.38%	-	0.08%
Return on Capital (ROIC)	1.59%	1.83%	-	2.09%	-	0.12%
Return on Capital Employed (ROCE)	7.30%	6.50%	10.60%	4.40%	17.70%	0.20%
Earnings Yield	2.09%	4.69%	8.74%	12.88%	23.00%	17.03%
FCF Yield	-57.48%	-171.50%	-27.27%	52.60%	-37.59%	-69.46%
Dividend Yield	5.19%	9.88%	-	-	-	-
Payout Ratio	261.55%	198.40%	91.57%	172.58%	31.18%	59.58%
Buyback Yield / Dilution	0.28%	-	-0.01%	1.82%	-1.85%	8.42%
Total Shareholder Return	5.65%	9.88%	-0.01%	1.82%	-1.85%	8.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.